Do analysts recommend KIDS or ZJYL?

OrthoPediatrics presently has a consensus price target of $26.50, suggesting a potential upside of 22.40%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, research analysts clearly believe OrthoPediatrics is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OrthoPediatrics 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, KIDS or ZJYL?

Jin Medical International has lower revenue, but higher earnings than OrthoPediatrics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OrthoPediatrics $236.35M 2.39 -$39.65M -$1.68 N/A Jin Medical International $20.69M 15.75 $1.19M N/A N/A

Does the media refer more to KIDS or ZJYL?

In the previous week, OrthoPediatrics had 2 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for OrthoPediatrics and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat OrthoPediatrics' score of 0.53 indicating that Jin Medical International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Jin Medical International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend SSII or ZJYL?

SS Innovations International presently has a consensus target price of $7.00, suggesting a potential upside of 165.15%. Given SS Innovations International's higher probable upside, equities research analysts clearly believe SS Innovations International is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SS Innovations International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, SSII or ZJYL?

Jin Medical International has lower revenue, but higher earnings than SS Innovations International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SS Innovations International $42.49M 12.45 -$12.13M -$0.06 N/A Jin Medical International $20.69M 15.75 $1.19M N/A N/A

Do analysts prefer DCTH or ZJYL?

Delcath Systems presently has a consensus price target of $23.17, indicating a potential upside of 50.82%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts clearly believe Delcath Systems is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, DCTH or ZJYL?

Delcath Systems has higher revenue and earnings than Jin Medical International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delcath Systems $85.23M 6.25 $2.70M $0.01 1,536.00 Jin Medical International $20.69M 15.75 $1.19M N/A N/A

Does the media prefer DCTH or ZJYL?

In the previous week, Delcath Systems had 2 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for Delcath Systems and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat Delcath Systems' score of -1.04 indicating that Jin Medical International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative Jin Medical International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend BWAY or ZJYL?

Brainsway currently has a consensus target price of $18.20, indicating a potential upside of 54.63%. Given Brainsway's stronger consensus rating and higher probable upside, analysts clearly believe Brainsway is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brainsway 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, BWAY or ZJYL?

Brainsway has higher revenue and earnings than Jin Medical International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Brainsway $52.22M 9.07 $7.57M $0.44 26.75 Jin Medical International $20.69M 15.75 $1.19M N/A N/A

Does the media refer more to BWAY or ZJYL?

In the previous week, Brainsway had 4 more articles in the media than Jin Medical International. MarketBeat recorded 6 mentions for Brainsway and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat Brainsway's score of 0.61 indicating that Jin Medical International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brainsway 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Jin Medical International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer SGHT or ZJYL?

Sight Sciences currently has a consensus price target of $8.38, suggesting a potential downside of 5.79%. Given Sight Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe Sight Sciences is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sight Sciences 1 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, SGHT or ZJYL?

Jin Medical International has lower revenue, but higher earnings than Sight Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sight Sciences $77.36M 6.33 -$38.43M -$0.56 N/A Jin Medical International $20.69M 15.75 $1.19M N/A N/A

Does the media favor SGHT or ZJYL?

In the previous week, Sight Sciences had 12 more articles in the media than Jin Medical International. MarketBeat recorded 14 mentions for Sight Sciences and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat Sight Sciences' score of 0.39 indicating that Jin Medical International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sight Sciences 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Jin Medical International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Jin Medical International (ZJYL) Competitors

$2.06 -0.06 (-2.83%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$2.05 -0.01 (-0.34%)

As of 10/9/2026 07:51 PM Eastern

Compare

ZJYL vs. KIDS, SSII, DCTH, BWAY, and SGHT

Should you buy Jin Medical International stock or one of its competitors? Jin Medical International's main competitors and comparable companies include OrthoPediatrics (KIDS), SS Innovations International (SSII), Delcath Systems (DCTH), Brainsway (BWAY), and Sight Sciences (SGHT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Jin Medical International compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

69.1% of OrthoPediatrics shares are owned by institutional investors. 32.5% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Jin Medical International has a net margin of 0.00% compared to OrthoPediatrics' net margin of -15.72%. Jin Medical International's return on equity of 0.00% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
Jin Medical International	N/A	N/A	N/A

Jin Medical International has lower revenue, but higher earnings than OrthoPediatrics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.39	-$39.65M	-$1.68	N/A
Jin Medical International	$20.69M	15.75	$1.19M	N/A	N/A

OrthoPediatrics presently has a consensus price target of $26.50, suggesting a potential upside of 22.40%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, research analysts clearly believe OrthoPediatrics is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

OrthoPediatrics has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.4, indicating that its stock price is 640% more volatile than the broader market.

In the previous week, OrthoPediatrics had 2 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for OrthoPediatrics and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat OrthoPediatrics' score of 0.53 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jin Medical International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OrthoPediatrics and Jin Medical International tied by winning 7 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to SS Innovations International?

SS Innovations International (NASDAQ:SSII) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

SS Innovations International has a beta of -1.79, meaning that its share price is 279% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.4, meaning that its share price is 640% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to SS Innovations International's net margin of -23.73%. Jin Medical International's return on equity of 0.00% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
Jin Medical International	N/A	N/A	N/A

In the previous week, SS Innovations International had 7 more articles in the media than Jin Medical International. MarketBeat recorded 9 mentions for SS Innovations International and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat SS Innovations International's score of 0.29 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jin Medical International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Jin Medical International has lower revenue, but higher earnings than SS Innovations International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	12.45	-$12.13M	-$0.06	N/A
Jin Medical International	$20.69M	15.75	$1.19M	N/A	N/A

SS Innovations International presently has a consensus target price of $7.00, suggesting a potential upside of 165.15%. Given SS Innovations International's higher probable upside, equities research analysts clearly believe SS Innovations International is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Jin Medical International beats SS Innovations International on 7 of the 10 factors compared between the two stocks.

How does Jin Medical International compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Delcath Systems had 2 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for Delcath Systems and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat Delcath Systems' score of -1.04 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative
Jin Medical International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

61.1% of Delcath Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Delcath Systems presently has a consensus price target of $23.17, indicating a potential upside of 50.82%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts clearly believe Delcath Systems is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Delcath Systems has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.4, indicating that its stock price is 640% more volatile than the broader market.

Delcath Systems has a net margin of 0.56% compared to Jin Medical International's net margin of 0.00%. Delcath Systems' return on equity of 0.46% beat Jin Medical International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.56%	0.46%	0.42%
Jin Medical International	N/A	N/A	N/A

Delcath Systems has higher revenue and earnings than Jin Medical International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	6.25	$2.70M	$0.01	1,536.00
Jin Medical International	$20.69M	15.75	$1.19M	N/A	N/A

Summary

Delcath Systems beats Jin Medical International on 11 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Brainsway?

Brainsway (NASDAQ:BWAY) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

Brainsway has higher revenue and earnings than Jin Medical International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Brainsway	$52.22M	9.07	$7.57M	$0.44	26.75
Jin Medical International	$20.69M	15.75	$1.19M	N/A	N/A

Brainsway currently has a consensus target price of $18.20, indicating a potential upside of 54.63%. Given Brainsway's stronger consensus rating and higher probable upside, analysts clearly believe Brainsway is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Brainsway	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

30.1% of Brainsway shares are owned by institutional investors. 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Brainsway had 4 more articles in the media than Jin Medical International. MarketBeat recorded 6 mentions for Brainsway and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat Brainsway's score of 0.61 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Brainsway	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jin Medical International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Brainsway has a net margin of 15.65% compared to Jin Medical International's net margin of 0.00%. Brainsway's return on equity of 12.74% beat Jin Medical International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Brainsway	15.65%	12.74%	8.17%
Jin Medical International	N/A	N/A	N/A

Brainsway has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.4, meaning that its stock price is 640% more volatile than the broader market.

Summary

Brainsway beats Jin Medical International on 11 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

55.5% of Sight Sciences shares are held by institutional investors. 30.4% of Sight Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sight Sciences has a beta of 2.45, indicating that its stock price is 145% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.4, indicating that its stock price is 640% more volatile than the broader market.

Sight Sciences currently has a consensus price target of $8.38, suggesting a potential downside of 5.79%. Given Sight Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe Sight Sciences is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Sight Sciences had 12 more articles in the media than Jin Medical International. MarketBeat recorded 14 mentions for Sight Sciences and 2 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.67 beat Sight Sciences' score of 0.39 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sight Sciences	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jin Medical International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Jin Medical International has a net margin of 0.00% compared to Sight Sciences' net margin of -35.69%. Jin Medical International's return on equity of 0.00% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-35.69%	-43.39%	-22.86%
Jin Medical International	N/A	N/A	N/A

Jin Medical International has lower revenue, but higher earnings than Sight Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	6.33	-$38.43M	-$0.56	N/A
Jin Medical International	$20.69M	15.75	$1.19M	N/A	N/A

Summary

Sight Sciences and Jin Medical International tied by winning 7 of the 14 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZJYL vs. The Competition

Export

Metric	Jin Medical International	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$335.37M	$5.44B	$7.16B	$13.21B
Dividend Yield	N/A	1.78%	2.53%	16.37%
P/E Ratio	N/A	25.57	274.15	26.16
Price / Sales	15.75	83.25	635.98	113.06
Price / Cash	11.57	31.87	76.38	53.09
Price / Book	0.54	5.93	11.21	6.34
Net Income	$1.19M	$146.18M	$3.50B	$381.90M
7 Day Performance	6.19%	-0.38%	-0.90%	-1.41%
1 Month Performance	N/A	-2.02%	-4.44%	-3.48%
1 Year Performance	-75.60%	5.08%	6.96%	1.16%

Jin Medical International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZJYL Jin Medical International	1.3506 of 5 stars	$2.06 -2.8%	N/A	-76.3%	$335.37M	$20.69M	N/A	273	Gap Down
KIDS OrthoPediatrics	3.2034 of 5 stars	$22.19 -2.5%	$26.44 +19.2%	+20.6%	$578.73M	$252.72M	N/A	602	Positive News
SSII SS Innovations International	1.6029 of 5 stars	$2.85 -1.4%	$7.00 +145.6%	-63.4%	$565.09M	$52.40M	N/A	483	News Coverage
DCTH Delcath Systems	3.0025 of 5 stars	$15.94 +0.6%	$23.17 +45.3%	+41.2%	$553.62M	$95.42M	1,597.10	156	News Coverage Negative News Analyst Downgrade
BWAY Brainsway	4.5893 of 5 stars	$13.30 -1.4%	$18.20 +36.9%	+51.3%	$533.67M	$60.70M	30.18	129

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZJYL) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jin Medical International (ZJYL) Competitors

ZJYL vs. KIDS, SSII, DCTH, BWAY, and SGHT

How does Jin Medical International compare to OrthoPediatrics?

Summary

How does Jin Medical International compare to SS Innovations International?

Summary

How does Jin Medical International compare to Delcath Systems?

Summary

How does Jin Medical International compare to Brainsway?

Summary

How does Jin Medical International compare to Sight Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZJYL vs. The Competition

Jin Medical International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jin Medical International (ZJYL) Competitors

ZJYL vs. KIDS, SSII, DCTH, BWAY, and SGHT

How does Jin Medical International compare to OrthoPediatrics?

Do institutionals and insiders have more ownership in KIDS or ZJYL?

Is KIDS or ZJYL more profitable?

Which has stronger valuation and earnings, KIDS or ZJYL?

Do analysts recommend KIDS or ZJYL?

Which has more risk and volatility, KIDS or ZJYL?

Does the media refer more to KIDS or ZJYL?

Summary

How does Jin Medical International compare to SS Innovations International?

Which has more volatility & risk, SSII or ZJYL?

Is SSII or ZJYL more profitable?

Does the media favor SSII or ZJYL?

Which has preferable earnings and valuation, SSII or ZJYL?

Do analysts recommend SSII or ZJYL?

Summary

How does Jin Medical International compare to Delcath Systems?

Does the media prefer DCTH or ZJYL?

Do institutionals & insiders have more ownership in DCTH or ZJYL?

Do analysts prefer DCTH or ZJYL?

Which has more risk & volatility, DCTH or ZJYL?

Is DCTH or ZJYL more profitable?

Which has higher earnings & valuation, DCTH or ZJYL?

Summary

How does Jin Medical International compare to Brainsway?

Which has better earnings & valuation, BWAY or ZJYL?

Do analysts recommend BWAY or ZJYL?

Do insiders & institutionals have more ownership in BWAY or ZJYL?

Does the media refer more to BWAY or ZJYL?

Is BWAY or ZJYL more profitable?

Which has more risk and volatility, BWAY or ZJYL?

Summary

How does Jin Medical International compare to Sight Sciences?

Do insiders & institutionals have more ownership in SGHT or ZJYL?

Which has more volatility and risk, SGHT or ZJYL?

Do analysts prefer SGHT or ZJYL?

Does the media favor SGHT or ZJYL?

Is SGHT or ZJYL more profitable?

Which has better earnings & valuation, SGHT or ZJYL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZJYL vs. The Competition

Jin Medical International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools